Asepsis announces the launch of Caspofungin Acetate for Injection in India. This is Asepsis’s second product launch in India. Asepsis plans to launch several more products in India in 2014. Caspofungin is one of the first in the advanced anti-fungal drug class called echinocandis. These antifungals are indicated for the treatment of serious and/or resistant infections. It is often used in patients who cannot use or do not respond to other antifungal medications.
Asepsis Pharmaceuticals™ , Inc. announces the product launch of Colistimethate Sodium for Injection in India. This is the first of several product launches Asepsis has planned for India. Colistimethate sodium is used to treat Pseudomonas aeruginosa infections in cystic fibrosis patients, however has recently been indicated and received worldwide notice for use in treating multidrug-resistant infection and is one of the last-resort antibiotics for multidrug-resistant Pseudomonas aeruginosa, Acinetobacter and New Delhi metallo-β-lactamase multidrug-resistant Enterobacteriaceae, also known as the New Deli Superbug.
Asepsis announces the launch of Colistimethate Sodium for Injection in South Korea. This is Asepsis first product launch in South Korea. Asepsis has plans for a product line extension in the near future. Colistimethate sodium is used to treat Pseudomonas aeruginosa infections in cystic fibrosis patients, however has recently been indicated and received worldwide notice for use in treating multidrug-resistant infection and is one of the last-resort antibiotics for multidrug-resistant Pseudomonas aeruginosa, Acinetobacter and New Delhi metallo-β-lactamase multidrug-resistant Enterobacteriaceae, also known as the New Deli Superbug.
Asepsis announces the launch of Caspofungin Acetate for Injection in India. This is Asepsis’s second product launch in India. Asepsis plans to launch several more products in India in 2014. Caspofungin is one of the first in the advanced anti-fungal drug class called echinocandis. These antifungals are indicated for the treatment of serious and/or resistant infections. It is often used in patients who cannot use or do not respond to other antifungal medications.
